A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
Conditions
Lung Neoplasm Malignant
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Clermont Oncology Center ( Site 0041), Clermont, Florida, United States
University of Illinois Hospital & Health Sciences System ( Site 0044), Chicago, Illinois, United States
Fundação Pio XII - Hospital de Câncer de Barretos ( Site 0282), Barretos, São Paulo, Brazil
Fundação Faculdade Regional de Medicina de São José do Rio Preto ( Site 0286), São José do Rio Preto, São Paulo, Brazil
Hospital Paulistano ( Site 0280), São Paulo, São Paulo, Brazil
Centro de Estudios Clínicos SAGA-CECSAGA ( Site 0162), Santiago, Region M. de Santiago, Chile
FALP ( Site 0161), Santiago, Region M. de Santiago, Chile
Bradfordhill ( Site 0160), Santiago, Region M. de Santiago, Chile
Guangdong Provincial People s Hospital ( Site 0300), Guangzhou, Guangdong, China
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA" ( Site 0204), Athens, Attica, Greece
Alexandra General Hospital of Athens-ONCOLOGY DEPT. ( Site 0205), Athens, Attica, Greece
Queen Mary Hospital ( Site 0230), Hong Kong, Hong Kong
Shaare Zedek Medical Center ( Site 0186), Jerusalem, Israel
Sheba Medical Center ( Site 0180), Ramat Gan, Israel
Severance Hospital, Yonsei University Health System ( Site 0080), Seoul, South Korea
Institut Català d'Oncologia - L'Hospitalet ( Site 0090), Hospitalet, Barcelona, Spain
Hospital Clinic de Barcelona ( Site 0092), Barcelona, Spain
Hospital Universitario Virgen Macarena ( Site 0093), Seville, Spain
Study leads
Medical Director
Study Director
Merck Sharp & Dohme LLC